• 2000 Citations
  • 25 h-Index
19942019
If you made any changes in Pure these will be visible here soon.

Research Output 1994 2019

  • 2000 Citations
  • 25 h-Index
  • 103 Article
  • 2 Letter
  • 2 Review article
  • 1 Comment/debate
Filter
Letter
2016
9 Citations (Scopus)

Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: A 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial

Hong, S., Park, C. Y., Han, K. A., Chung, C. H., Ku, B. J., Jang, H. C., Ahn, C. W., Lee, M. K., Moon, M. K., Son, H. S., Lee, C. B., Cho, Y. W. & Park, S. W., 2016 May 1, In : Diabetes, Obesity and Metabolism. 18, 5, p. 528-532 5 p.

Research output: Contribution to journalLetter

Dipeptidyl-Peptidase IV Inhibitors
Type 2 Diabetes Mellitus
Placebos
Safety
Glycosylated Hemoglobin A
2015
9 Citations (Scopus)

Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: A 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension

Jin, S. M., Park, S. W., Yoon, K. H., Min, K. W., Song, K. H., Park, K. S., Park, J. Y., Park, I. B., Chung, C. H., Baik, S. H., Choi, S. H., Lee, H. W., Lee, I. K., Kim, D. M. & Lee, M. K., 2015 May 1, In : Diabetes, Obesity and Metabolism. 17, 5, p. 511-515 5 p.

Research output: Contribution to journalLetter

Phase III Clinical Trials
Metformin
Type 2 Diabetes Mellitus
Safety
Insulin